Genedata, a leading provider of advanced software solutions for agribusiness, industrial biotechnology, pharmaceuticals and related life science research, today announced the release of Genedata Selector 4.0. This latest version of the industry’s leading genome knowledge management solution provides groundbreaking new capabilities for reference-independent genome sequence comparisons while reducing data processing and analysis time. Genedata Selector 4.0’s powerful new comparative genomics functionalities make it possible for the first time to compare and interpret genomic variants across assemblies and sequencing approaches. At the same time, the new automated processing pipeline optimizes user efficiency and lowers costs throughout the workflow, from integrating new knowledge, maintaining existing knowledge and interpreting data to generating reports.
First-In-Class Reference-Independent Genomic Comparison and Analyses Across Lineages: Genedata Selector 4.0 Addresses Current Challenges
High-quality reference genomes serve important roles in identifying and understanding genomic variants across strains and lines. As new reference assemblies become available over time, organizations are faced with a significant challenge in order to retain existing knowledge and integrate it with the new references. Information from past analyses and the related intellectual property is often lost or dispersed over time, and no longer available for use in the discovery process. For researchers, the comparison of variants across reference systems is a difficult and time-consuming task, while for bioinformaticians, the re-alignment of historic data to new reference genomes is a challenge. Other data management systems that store variants relative to reference assemblies do not enable the performance of analyses that span different reference systems, or between genomes that are assembled without a reference genome (for example, de novo sequencing methods). Keeping all of the constantly accumulating variant knowledge current and accurate involves vast amounts of data, placing high demands on hardware and IT resources. As sequencing costs decrease and de novo sequencing approaches become more prevalent, there is a pressing need for knowledge management solutions with fewer limitations which reduce pressure on resources.
Genedata Selector 4.0 has been specially designed to meet these challenges. New genome assemblies and re-sequenced genomes can now be easily integrated with existing genomic knowledge through a new processing pipeline which automatically updates variant data from previous analyses. Users now have the ability to analyze genomic sequences and protein affects across any available reference assembly. This includes choosing a reference from within the user interface, or directly comparing variants independent of any reference genome.
Highlights of the new version of Genedata Selector:
These new features are tightly integrated with the robust knowledge management and data analysis capabilities of the platform - capabilities currently valued by customers across a wide range of industries. Within a single, integrated framework, Genedata Selector manages and analyzes genome-related data for strain and cell line optimization.
“We are very proud to provide organizations with unique functionalities integrated in a single platform to generate new insights into their data while creating efficiencies and reducing costs,” said Dr. Othmar Pfannes, CEO of Genedata. “With version 4.0, we enable researchers to fully leverage the most advanced technologies used in genome-based research and we are firmly committed to continually advancing this platform to meet their emerging needs.”
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. www.genedata.com. Follow us on LinkedIn.
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.